LIFE SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2025-09-15 ms5000000488529639 来自吉林省

非常奇怪的杂志
1. Sep 8 2025 8:42AM With editor
2. Sep 11 2025 7:54AM Submitted to Journal

今天15号了仍然是Submitted to Journal 状态

32 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2025-08-31 ms7000002977722171 来自上海

主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。
投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。
重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。

43 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2025-09-04 1564372428m 来自安徽省

审稿速度:1.0 | 投稿命中率:5.0
经验分享：WE已经20天了

42 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2025-09-12 jiongjiong830 来自山东省

杂志还没送审就让Data Visualizations，可以拒绝吗

39 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2025-02-12 ms8000001174824878 来自亚利桑那

偏重的研究方向：生殖疾病
经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。

81 11 举报

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2025-03-30 ms3000002140122840 来自江西省

偏重的研究方向：炎症;心血管
经验分享：要求提供重复3次WB原始图片

70 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2025-05-13 ms7000001521382885 来自北京

请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗

76 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2025-01-09 ms7000000536537559 来自湖北省

偏重的研究方向：心血管
经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等

97 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2024-09-01 ms2000000973583706 来自四川省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：基础研究
经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了

89 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2281285, encodeId=eb182281285d0, content=非常奇怪的杂志 1. Sep 8 2025 8:42AM With editor 2. Sep 11 2025 7:54AM Submitted to Journal 今天15号了仍然是Submitted to Journal 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=affb5630821, createdName=ms5000000488529639, createdTime=Mon Sep 15 09:15:33 CST 2025, time=2025-09-15, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2279514, encodeId=512a22e9514a4, content=主要收录生物化学、分子生物学、细胞生物学、药理学等生命科学领域基础及具临床转化潜力的研究，强调疾病相关分子、细胞和功能机制。 投稿时，语言得用英语，稿件最好控制在 10 - 25 页，格式选 word、PDF 等都可。 重复率要在 10% 内，文献超 25 条且近 5 年占一半以上。期刊审稿严谨，通常会邀请 3 - 4 位审稿人，整个审稿周期预计约 6 个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Sun Aug 31 22:25:58 CST 2025, time=2025-08-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2280013, encodeId=31e222800130f, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：WE已经20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3c4788486, createdName=1564372428m, createdTime=Thu Sep 04 17:34:42 CST 2025, time=2025-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2281025, encodeId=cd3222810253f, content=杂志还没送审就让Data Visualizations，可以拒绝吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=SnwXPRWOWMVgUqAZUK4xIA&s=100&t=1556719178, createdBy=bfc75213462, createdName=jiongjiong830, createdTime=Fri Sep 12 15:31:15 CST 2025, time=2025-09-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2251576, encodeId=8fad22515e6c6, content=偏重的研究方向：生殖疾病 经验分享：请问前辈们，2月9号投稿，期间看到submit to journal然后到with editor ，2月11号变成Decision in Process，请问这个还有机会送外审吗，还是跟其他看到的经验贴说的一样马上就要被拒了呢，万分感谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24be9412424, createdName=ms8000001174824878, createdTime=Wed Feb 12 10:03:31 CST 2025, time=2025-02-12, status=1, ipAttribution=亚利桑那), GetPortalCommentsPageByObjectIdResponse(id=2258375, encodeId=e5b022583e564, content=偏重的研究方向：炎症;心血管 经验分享：要求提供重复3次WB原始图片, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14cd9417760, createdName=ms3000002140122840, createdTime=Sun Mar 30 13:03:05 CST 2025, time=2025-03-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2264794, encodeId=c9902264e94f7, content=请问有没有最近1周投稿的朋友呀，我5月7号投的，第6天了现在还是submit to journal，这个杂志submit状态代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:03:31 CST 2025, time=2025-05-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2247237, encodeId=8e6f224e2374a, content=偏重的研究方向：心血管 经验分享：投稿综述，投了大概十天，因为字数超了，编辑打回来让我删减字数和参考文献。重新提交之后第四天就送审，总的来说还是很快的。但是目前邀请了12个审稿人，等了好几天也就2个审稿人同意审稿。我想问一下这个杂志一般需要几个审稿人，不想一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4db95624528, createdName=ms7000000536537559, createdTime=Thu Jan 09 11:13:18 CST 2025, time=2025-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2223591, encodeId=9d1922235912c, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础研究 经验分享：请问外审3个月了正常吗？5月底under review，6月底更新了一下时间，但还是under review，现在还在，这个速度是不是太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c658434920, createdName=ms2000000973583706, createdTime=Sun Sep 01 21:20:22 CST 2024, time=2024-09-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2264793, encodeId=6ca12264e9306, content=偏重的研究方向：肿瘤学;基础研究;生命科学 经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue May 13 10:01:02 CST 2025, time=2025-05-13, status=1, ipAttribution=北京)]

2025-05-13 ms7000001521382885 来自北京

偏重的研究方向：肿瘤学;基础研究;生命科学
经验分享：有没有刚投的呀，我5.7号投的，现在还是submit to journal，这个杂志submit to journal代表技术审查吗

69 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务